Analystreport

Galectin Therapeutics Inc. (NASDAQ: GALT) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating.

Galectin Therapeutics Inc.  (GALT) 
Last galectin therapeutics inc. earnings: 11/12 08:00 am Check Earnings Report